HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 45649,
"recordsTotal": 45649,
"next": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=status&start=44100",
"previous": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=status&start=43500",
"results": [
{
"registry_id": "NCT06007937",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06007937",
"title": "A Phase 1/2 Study of Combination Lorlatinib and Ramucirumab in Patients With Advanced ALK-rearranged Lung Cancers",
"has_exemption": false,
"start_date": "2023-08-17",
"completion_date": "2028-08-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06843967",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06843967",
"title": "A Phase Ib/II Study of the Mirdametinib in Combination With Palbociclib in Patients With Advanced Dedifferentiated Liposarcoma",
"has_exemption": false,
"start_date": "2025-02-19",
"completion_date": "2028-08-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06292780",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06292780",
"title": "A Phase 1/2 Study of Linvoseltamab in Patients With Relapsed or Refractory Systemic Light Chain Amyloidosis",
"has_exemption": false,
"start_date": "2024-08-07",
"completion_date": "2028-08-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05985915",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05985915",
"title": "A Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.",
"has_exemption": false,
"start_date": "2023-10-27",
"completion_date": "2028-08-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06425549",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06425549",
"title": "A Multicenter, Randomized, Parallel-Group, Double-Blind, Active-Controlled Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis",
"has_exemption": false,
"start_date": "2024-06-25",
"completion_date": "2028-08-21",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06597565",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06597565",
"title": "A Phase II Study of ACR-368 and Low Dose Gemcitabine Combination Therapy in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2024-09-25",
"completion_date": "2028-08-23",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06165341",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06165341",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Fazirsiran in the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease With METAVIR Stage F1 Fibrosis",
"has_exemption": false,
"start_date": "2024-03-01",
"completion_date": "2028-08-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03888105",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03888105",
"title": "An Open-Label Study to Assess the Anti-Tumor Activity and Safety of REGN1979, an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2019-11-13",
"completion_date": "2028-08-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05805826",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05805826",
"title": "A PHASE 1/2 RANDOMIZED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, IMMUNOGENICITY, AND IMMUNOPERSISTENCE OF A CLOSTRIDIOIDES DIFFICILE VACCINE ADMINISTERED WITH NOVEL ADJUVANTS IN HEALTHY ADULTS",
"has_exemption": false,
"start_date": "2023-03-23",
"completion_date": "2028-08-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05843253",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05843253",
"title": "PhaseII Study of Ribociclib and Everolimus Following Radiotherapy in Pediatric and Young Adult Patients Newly Diagnosed With HGG Including DIPG, Which Harbor Alterations of the Cell Cycle and/or PI3K/mTOR Pathways",
"has_exemption": false,
"start_date": "2024-08-22",
"completion_date": "2028-08-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Nationwide Children's Hospital",
"sponsor_slug": "nationwide-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06780449",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06780449",
"title": "Long-term Efficacy and Safety of Cagrilintide s.c. 2.4 mg in Combination With Semaglutide s.c. 2.4 mg (CagriSema 2.4 mg/2.4 mg) Once Weekly Versus Placebo in Participants With Obesity",
"has_exemption": false,
"start_date": "2025-02-10",
"completion_date": "2028-08-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06531824",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06531824",
"title": "A Multicenter, International, Randomized, Double-blind, Placebo-controlled Clinical Trial of the Aldosterone Synthase Inhibitor BI 690517 in Combination With Empagliflozin in Patients With Chronic Kidney Disease",
"has_exemption": false,
"start_date": "2024-08-13",
"completion_date": "2028-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06858397",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06858397",
"title": "An Open Label, Dose Range, Proof-of-Concept Study to Assess the Safety and Efficacy of HM15421/GC1134A in Patients With Fabry Disease",
"has_exemption": false,
"start_date": "2025-05-14",
"completion_date": "2028-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "GC Biopharma Corp",
"sponsor_slug": "gc-biopharma-corp",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06975150",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06975150",
"title": "A Randomized, Double-blind, Placebo-controlled, Parallel Group, 12 Weeks, Phase 2b Clinical Study to Evaluate the Efficacy and Safety of HK-660S in Patients With Primary Sclerosing Cholangitis (PSC)",
"has_exemption": false,
"start_date": "2025-08-18",
"completion_date": "2028-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "CuromeBiosciences",
"sponsor_slug": "curomebiosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02530073",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02530073",
"title": "Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Left Congenital Diaphragmatic Hernia (CDH)",
"has_exemption": false,
"start_date": "2015-09-30",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Connecticut Children's Medical Center",
"sponsor_slug": "connecticut-childrens-medical-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03008408",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03008408",
"title": "A Phase II, Randomized Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (LEE011) in Patients With Advanced or Recurrent Endometrial Carcinoma",
"has_exemption": false,
"start_date": "2017-08-18",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03921008",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03921008",
"title": "Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma",
"has_exemption": false,
"start_date": "2019-05-21",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03516279",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03516279",
"title": "Phase II Study of Adding the Anti-PD-1 Pembrolizumab to Tyrosine Kinase Inhibitors in Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease",
"has_exemption": false,
"start_date": "2019-06-26",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03929432",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03929432",
"title": "Treatment Outcomes and Brain Mechanisms Associated With Non-Invasive Neuromodulation in Post-Stroke Aphasia",
"has_exemption": false,
"start_date": "2019-09-03",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arkansas",
"sponsor_slug": "university-of-arkansas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04499248",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04499248",
"title": "A Phase 1/2 Study to Evaluate the Safety and Efficacy of AGN-193408 SR in Participants With Open-Angle Glaucoma or Ocular Hypertension",
"has_exemption": false,
"start_date": "2020-11-16",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04873362",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04873362",
"title": "A Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy",
"has_exemption": false,
"start_date": "2021-05-04",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05004116",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05004116",
"title": "Phase 1/2 Study of TPX-0005 (Repotrectinib) in Combination With Chemotherapy in Pediatric and Young Adult Subjects With Advanced or Metastatic Solid Tumors and Primary Central Nervous System Tumors",
"has_exemption": false,
"start_date": "2021-08-09",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04747431",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04747431",
"title": "A Phase 1b Open-Label, Multicenter, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacodynamic Effects of a Single Dose of PBFT02 Delivered Into the ICM of Adults With FTD and Mutations in the GRN or C9ORF72 Genes",
"has_exemption": false,
"start_date": "2021-09-14",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Passage Bio, Inc.",
"sponsor_slug": "passage-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04831580",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04831580",
"title": "A Randomized Controlled Trial of Robotic Versus Open Surgery for Early Stage Cervical Cancer (ROCC)",
"has_exemption": false,
"start_date": "2022-03-22",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "GOG Foundation",
"sponsor_slug": "gog-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05467891",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05467891",
"title": "A Phase II Study of Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer",
"has_exemption": false,
"start_date": "2022-09-13",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Oana Danciu",
"sponsor_slug": "oana-danciu",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05456503",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05456503",
"title": "Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Disease Using the PET Ligand PI-2620",
"has_exemption": false,
"start_date": "2022-09-19",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05501756",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05501756",
"title": "Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation in Non-Malignant Diseases",
"has_exemption": false,
"start_date": "2023-01-11",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Medical Center, Cincinnati",
"sponsor_slug": "childrens-hospital-medical-center-cincinnati",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05498220",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05498220",
"title": "A Phase II Trial Evaluating the Efficacy of Polatuzumab Vedotin With Rituximab, Gemcitabine, Dexamethasone, and Cisplatin (PV-RGDP) Chemotherapy for Relapsed or Refractory Diffuse Large B-cell Lymphoma",
"has_exemption": false,
"start_date": "2023-02-17",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05585554",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05585554",
"title": "Locally Advanced Pancreatic Cancer Treated With ABLAtivE Stereotactic MRI-guided Adaptive Radiation Therapy (LAP-ABLATE)",
"has_exemption": false,
"start_date": "2023-07-31",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Viewray Inc.",
"sponsor_slug": "viewray-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06000787",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06000787",
"title": "Molecular Characterization Trial for the Harvard/UCSF ROBIN Center: Radiation Oncology at the Interface of Pediatric Cancer Biology and Data Science",
"has_exemption": false,
"start_date": "2023-09-19",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05782907",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05782907",
"title": "A Phase 3 Multicenter Study to Evaluate Efficacy, Safety, and Pharmacokinetics of Upadacitinib With Open-Label Induction, Randomized, Double-Blind Maintenance and Open-Label Long-Term Extension in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis and Inadequate Response, Intolerance, or Medical Contraindications to Corticosteroids, Immunosuppressants, and/or Biologic Therapy",
"has_exemption": false,
"start_date": "2023-11-06",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06181136",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06181136",
"title": "A Phase 1/2, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL126 in Pediatric Participants With Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome Type A)",
"has_exemption": false,
"start_date": "2023-12-07",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Denali Therapeutics Inc.",
"sponsor_slug": "denali-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05953610",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05953610",
"title": "Endotypic Traits and Obstructive Sleep Apnea Surgery",
"has_exemption": false,
"start_date": "2024-01-07",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05237505",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05237505",
"title": "The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)",
"has_exemption": false,
"start_date": "2024-02-13",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05753046",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05753046",
"title": "Perioperative Laparoscopic Transversus Abdominis Plane Block During Robotic Assisted Laparoscopic Radical Prostatectomy for Improvement in Postoperative Pain",
"has_exemption": false,
"start_date": "2024-02-19",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "William Beaumont Hospitals",
"sponsor_slug": "william-beaumont-hospitals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06242782",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06242782",
"title": "Vertical Ridge Augmentation Strategies: An Adaptive Randomised Controlled Clinical Trial",
"has_exemption": false,
"start_date": "2024-02-29",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University College, London",
"sponsor_slug": "university-college-london",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06290063",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06290063",
"title": "Rocky Mountain Cannabis Research Center - Cannabidiol and Older Adult Cannabis Users: A Randomized, Placebo-Controlled Study",
"has_exemption": false,
"start_date": "2024-05-01",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Boulder",
"sponsor_slug": "university-of-colorado-boulder",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06082167",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06082167",
"title": "A Phase 2/3, Randomized, Double-Blind, Controlled Study of Zanzalintinib (XL092) in Combination With Pembrolizumab vs Pembrolizumab in First-Line Treatment of Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2024-06-07",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Exelixis",
"sponsor_slug": "exelixis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06239194",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06239194",
"title": "A Phase 1/2a, Multicenter, First-in-human, Open-label Clinical Trial Evaluating MDX2001 Monotherapy in Patients With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2024-06-12",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ModeX Therapeutics, An OPKO Health Company",
"sponsor_slug": "modex-therapeutics-an-opko-health-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05826912",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05826912",
"title": "Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury",
"has_exemption": false,
"start_date": "2024-08-01",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06377852",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06377852",
"title": "Comparing Oral Drug Dosing Strategies in Older Patients With Metastatic Breast Cancer to Maximize Tolerance and Reduce Discontinuation: The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study",
"has_exemption": false,
"start_date": "2024-10-29",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "American Society of Clinical Oncology",
"sponsor_slug": "american-society-of-clinical-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06624644",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06624644",
"title": "A Multicenter, Open-Label, Randomized, Controlled Study to Assess the Antitumor Activity of LNS8801 with and Without Pembrolizumab in Patients with Treatment-Refractory, Unresectable Melanoma",
"has_exemption": false,
"start_date": "2024-11-30",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Linnaeus Therapeutics, Inc.",
"sponsor_slug": "linnaeus-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06105164",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06105164",
"title": "Validation of a Novel Cerebellar-striatal Satiety Circuit in Humans",
"has_exemption": false,
"start_date": "2024-12-05",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06399653",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06399653",
"title": "Non-invasive Vagal Nerve Stimulation as Novel Treatment to Improve Functional Outcomes in Veterans With Alcohol Use Disorder",
"has_exemption": false,
"start_date": "2025-01-01",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06632951",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06632951",
"title": "A Phase 2, Open-Label, Randomized Study of Livmoniplimab in Combination With Budigalimab Versus Chemotherapy in Subjects With Metastatic Urothelial Carcinoma",
"has_exemption": false,
"start_date": "2025-01-20",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06136546",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06136546",
"title": "The Role of Inflammation in Cognitive Dysfunction in Acute Depression as Determined by Experimental Inhibition of Tumor Necrosis Factor-alpha Signaling in a Randomized Controlled Trial.",
"has_exemption": false,
"start_date": "2025-01-23",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06785116",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06785116",
"title": "A Randomized, Placebo-controlled Trial of DAPAgliflozin for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies",
"has_exemption": false,
"start_date": "2025-03-02",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07032662",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07032662",
"title": "A Phase 2b, Multi-center, Randomized, Double-blind, Placebo-controlled Study of IMVT-1402 Treatment in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)",
"has_exemption": false,
"start_date": "2025-03-18",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Immunovant Sciences GmbH",
"sponsor_slug": "immunovant-sciences-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06265584",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06265584",
"title": "Phase II Clinical Trial of 2 Step ATG Combined With Tacrolimus and Mini Methotrexate for Prevention of Acute GVHD Post Reduced Intensity Allogeneic Stem Cell Transplant",
"has_exemption": false,
"start_date": "2025-04-08",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06943521",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06943521",
"title": "A Phase I/II, Dose-escalation and Dose-optimization Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of MT-4561 in Patients With Various Advanced Solid Tumors and to Evaluate Effect of MT-4561 on Pharmacokinetics of Oral Midazolam",
"has_exemption": false,
"start_date": "2025-04-18",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mitsubishi Tanabe Pharma America Inc.",
"sponsor_slug": "mitsubishi-tanabe-pharma-america-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06939283",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06939283",
"title": "A Phase 1b/2 Multisite Dose- and Regimen-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma (NHL)",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Werewolf Therapeutics, Inc.",
"sponsor_slug": "werewolf-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06965127",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06965127",
"title": "Enhancing Walking and Independence After Incomplete SCI With a Fully Implanted Neuroprosthesis",
"has_exemption": false,
"start_date": "2025-05-31",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Cleveland VA Medical Research and Education Foundation",
"sponsor_slug": "cleveland-va-medical-research-and-education-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07001800",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07001800",
"title": "A Phase 3, Randomized, Double-Blinded, Placebo Controlled Study ChecKing the Efficacy and Safety of ATAciguat to Slow the Progression of VaLvular DYsfunction in Participants With Moderate Calcific Aortic Valve STenosis",
"has_exemption": false,
"start_date": "2025-06-27",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kardigan, Inc.",
"sponsor_slug": "kardigan-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06998407",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06998407",
"title": "A Phase 1/2, First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AVZO-023 as a Single Agent, and in Combination With AVZO-021 and/or Endocrine Therapy in Patients With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Avenzo Therapeutics, Inc.",
"sponsor_slug": "avenzo-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06933329",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06933329",
"title": "Phase 2 Study of Zelenectide Pevedotin in Participants With Previously-Treated NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-07-18",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BicycleTx Limited",
"sponsor_slug": "bicycletx-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07021989",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07021989",
"title": "Pembrolizumab and GVD With ctDNA-guided Consolidation in Patients With Relapsed or Refractory Classic Hodgkin Lymphoma: A Multicenter Phase 2 Study of the University of California Hematologic Malignancies Consortium",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Michael Spinner, MD",
"sponsor_slug": "michael-spinner-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06943859",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06943859",
"title": "Ketamine for the Treatment of Opioid Use Disorder",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, Baltimore",
"sponsor_slug": "university-of-maryland-baltimore",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07052695",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07052695",
"title": "A Pilot Study Evaluating Mosunetuzumab for Clearance of Detectable Minimal Residual Disease in Chronic Lymphocytic Leukemia",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Inhye Ahn",
"sponsor_slug": "inhye-ahn",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07089992",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07089992",
"title": "URSa-1: A Minibasket Study of Pembrolizumab in Ultra-Rare Sarcomas",
"has_exemption": false,
"start_date": "2025-08-11",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06749145",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06749145",
"title": "Deep Learning Enhanced Detection of Aortic Stenosis - The DETECT-AS-Diagnostic Study",
"has_exemption": false,
"start_date": "2025-08-15",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06678841",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06678841",
"title": "Randomized Trial of ELEVATEd Cardiac Pacing Rate for Personalized Treatment of Heart Failure With Preserved Ejection Fraction (ELEVATE-HFpEF)",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medtronic Cardiac Rhythm and Heart Failure",
"sponsor_slug": "medtronic-cardiac-rhythm-and-heart-failure",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06723015",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06723015",
"title": "Study of Tau PET Outcomes in Patients Receiving Anti-amyloid Immunotherapies",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06784336",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06784336",
"title": "Phase II Multi-center Study of Resistant Potato Starch Plus Deferasirox to Improve Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan Rogel Cancer Center",
"sponsor_slug": "university-of-michigan-rogel-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06813820",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06813820",
"title": "RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BioVentrix",
"sponsor_slug": "bioventrix",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06957691",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06957691",
"title": "Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy (Fezo-ADT Trial)",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Shehzad Basaria, M.D.",
"sponsor_slug": "shehzad-basaria-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07092475",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07092475",
"title": "The Impact of Intraoperative Methadone on Postoperative Opioid Use",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06835504",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06835504",
"title": "Efficacy of Intravenous Sub-Dissociative Ketamine Versus Intravenous Morphine in Children with Acute Pain",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Columbia University",
"sponsor_slug": "columbia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05809908",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05809908",
"title": "A Phase III, 26-Week, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of Daily Administration of Tricaprilin in Subjects with Mild to Moderately Severe Probable Alzheimer Disease",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Cerecin",
"sponsor_slug": "cerecin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06957418",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06957418",
"title": "The Alzheimer's Disease Tau Platform Clinical Trial",
"has_exemption": false,
"start_date": "2025-11-01",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Southern California",
"sponsor_slug": "university-of-southern-california",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04056013",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04056013",
"title": "Vicryl Rapide Versus Nonabsorbable Suture in Repair of Simple Traumatic Extremity and Trunk Lacerations in Adult Patients",
"has_exemption": false,
"start_date": "2019-09-26",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04140487",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04140487",
"title": "A Phase I/II Study of Azacitidine, Venetoclax, and Gilteritinib for Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome With an Activating FLT3 Mutation",
"has_exemption": false,
"start_date": "2019-12-17",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04209686",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04209686",
"title": "Phase 2 Study of Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma",
"has_exemption": false,
"start_date": "2020-07-31",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05100095",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05100095",
"title": "Hypofractionated Radiation Therapy for Merkel Cell Carcinoma",
"has_exemption": false,
"start_date": "2021-12-14",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05929729",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05929729",
"title": "Neurovascular and Neurocognitive Consequences of Iron Deficiency Anemia",
"has_exemption": false,
"start_date": "2023-12-07",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Los Angeles",
"sponsor_slug": "childrens-hospital-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06027086",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06027086",
"title": "A Phase 1b/2 Study of Glutamine Antagonist DRP-104 in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Hepatocellular Carcinoma (FLC)",
"has_exemption": false,
"start_date": "2024-02-12",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04875702",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04875702",
"title": "Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout: a Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2024-02-22",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05919329",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05919329",
"title": "Modulation of PSMA Expression in Castration Sensitive and Castration Resistant Prostate Cancer in Response to Hormonal Therapy",
"has_exemption": false,
"start_date": "2024-06-25",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "OHSU Knight Cancer Institute",
"sponsor_slug": "ohsu-knight-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06253117",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06253117",
"title": "Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis.",
"has_exemption": false,
"start_date": "2024-06-27",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06573996",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06573996",
"title": "The Effect of Intraoral Transcutaneous Electrical Nerve Stimulation (TENS) on Pain Perception During Orthodontic Alignment and Leveling: a Randomized Clinical Trial",
"has_exemption": false,
"start_date": "2024-09-16",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of the Pacific",
"sponsor_slug": "university-of-the-pacific",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06415591",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06415591",
"title": "Auricular Neuromodulation in Veterans With Fibromyalgia: A Randomized, Sham-Controlled Study",
"has_exemption": false,
"start_date": "2024-11-01",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06567314",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06567314",
"title": "Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2024-12-02",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06651593",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06651593",
"title": "Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors",
"has_exemption": false,
"start_date": "2025-04-15",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06883162",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06883162",
"title": "Randomized Controlled Trial of Varenicline to Treat Tobacco and Cannabis Co-Use (RECLAIM)",
"has_exemption": false,
"start_date": "2025-05-06",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07016399",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07016399",
"title": "A Phase II Neoadjuvant Clinical Trial of the Androgen Receptor Inhibitor Darolutamide in Early-Stage Androgen Receptor Positive (AR+) Triple-Negative Breast Cancer",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Vandana Abramson",
"sponsor_slug": "vandana-abramson",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06758401",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06758401",
"title": "AN OPEN-LABEL, RANDOMIZED, CONTROLLED PHASE 3 STUDY OF SIGVOTATUG VEDOTIN IN COMBINATION WITH PEMBROLIZUMAB COMPARED WITH PEMBROLIZUMAB MONOTHERAPY AS FIRST-LINE TREATMENT IN PARTICIPANTS WITH PD-L1 HIGH (≥50% OF TUMOR CELLS EXPRESSING PD-L1), LOCALLY ADVANCED, UNRESECTABLE, OR METASTATIC NON-SMALL CELL LUNG CANCER (BE6A LUNG-02)",
"has_exemption": false,
"start_date": "2025-05-04",
"completion_date": "2028-09-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05599360",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05599360",
"title": "Vyxeos for Induction of Newly Diagnosed Low- or Intermediate-risk AML Patients, Age 18-70. A Pilot Study",
"has_exemption": false,
"start_date": "2022-08-07",
"completion_date": "2028-09-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Shaare Zedek Medical Center",
"sponsor_slug": "shaare-zedek-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06963827",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06963827",
"title": "A Phase 3 Multicenter, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate Efficacy and Safety of Mezagitamab (TAK-079) in Study Participants With Primary IgA Nephropathy in Combination With Stable Background Therapy",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2028-09-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05611801",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05611801",
"title": "AN OPEN-LABEL STUDY IN PEDIATRIC (<18 YEARS OF AGE), SEVERE HEMOPHILIA A PARTICIPANTS (COAGULATION FACTOR ACTIVITY <1%) WITH OR WITHOUT INHIBITORS OR MODERATELY SEVERE TO SEVERE HEMOPHILIA B PARTICIPANTS (COAGULATION FACTOR ACTIVITY =2%) WITH OR WITHOUT INHIBITORS COMPARING 12 MONTHS OF HISTORICAL STANDARD TREATMENT TO MARSTACIMAB PROPHYLAXIS",
"has_exemption": false,
"start_date": "2022-12-09",
"completion_date": "2028-09-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06959641",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06959641",
"title": "A Phase 2 Open Label Study of XL092 as First Line Therapy in Radioiodine Refractory Differentiated Thyroid Cancer",
"has_exemption": false,
"start_date": "2025-06-06",
"completion_date": "2028-09-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06976216",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06976216",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for the Treatment of Cognitive Impairment Associated With Mild to Moderate Alzheimer's Disease (MINDSET 1)",
"has_exemption": false,
"start_date": "2025-07-25",
"completion_date": "2028-09-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06976203",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06976203",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for the Treatment of Cognitive Impairment Associated With Mild to Moderate Alzheimer's Disease (MINDSET 2)",
"has_exemption": false,
"start_date": "2025-07-25",
"completion_date": "2028-09-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06980480",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06980480",
"title": "A Multicenter, Randomized, Controlled, Open-label, Group-Sequential, Phase 3 Study to Investigate the Efficacy, Safety, and Tolerability of Intravenous Gammagard Liquid (Immune Globulin Infusion, 10%) for Primary Infection Prophylaxis Compared With Secondary Infection Prophylaxis in Adult Subjects With Multiple Myeloma Receiving B-Cell Maturation AntigenxCD3-Directed Bispecific Antibody Therapy",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2028-09-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06305754",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06305754",
"title": "A Randomized, Open-label, Phase 3 Study of MK-2870 vs. Platinum Doublets in Participants With EGFR-mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors",
"has_exemption": false,
"start_date": "2024-06-11",
"completion_date": "2028-09-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07028853",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07028853",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Mevrometostat (PF-06821497) With Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer (MEVPRO-3)",
"has_exemption": false,
"start_date": "2025-08-25",
"completion_date": "2028-09-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06847542",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06847542",
"title": "A Phase IIIb, Multicenter, Single-arm Study Assessing the Effectiveness, Safety and Patient Reported Outcomes of a 36-week Refill Exchange Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-related Macular Degeneration",
"has_exemption": false,
"start_date": "2025-11-18",
"completion_date": "2028-09-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05306353",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05306353",
"title": "Combining a CD40L-Binding Protein (VIB4920) With a TNF-alpha Inhibitor for the Treatment of Inadequately Controlled Rheumatoid Arthritis (ITN092AI)",
"has_exemption": false,
"start_date": "2023-07-25",
"completion_date": "2028-09-13",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05244486",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05244486",
"title": "Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-Prostatectomy",
"has_exemption": false,
"start_date": "2022-03-12",
"completion_date": "2028-09-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Charitable Union for the Research and Education of Peyronie's Disease",
"sponsor_slug": "charitable-union-for-the-research-and-education-of-peyronies-disease",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06872892",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06872892",
"title": "A Phase III, Randomised, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of BI 1291583 2.5 mg Administered Once Daily for up to 76 Weeks in Patients With Bronchiectasis (The AIRTIVITY® Study)",
"has_exemption": false,
"start_date": "2025-06-09",
"completion_date": "2028-09-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07094516",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07094516",
"title": "A Randomized, Placebo-controlled, Parallel Group, 72-week Study to Evaluate the Efficacy and Safety of VHB937 in Participants With Early Alzheimer's Disease Followed by an Extension",
"has_exemption": false,
"start_date": "2025-09-18",
"completion_date": "2028-09-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06175000",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06175000",
"title": "Maintenance Obinutuzumab for Primary Central Nervous System Lymphoma Complete or Partial Responders",
"has_exemption": false,
"start_date": "2024-03-13",
"completion_date": "2028-09-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Providence Health & Services",
"sponsor_slug": "providence-health-services",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06158828",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06158828",
"title": "A Phase I/II Pilot Study of Memory-like NK Cells to Consolidate TCRαβ T Cell Depleted Haploidentical Transplant in High-risk AML",
"has_exemption": false,
"start_date": "2024-05-15",
"completion_date": "2028-09-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06514547",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06514547",
"title": "Vaccine Immunity and Inflammation in the Aging Person Living With HIV",
"has_exemption": false,
"start_date": "2024-07-08",
"completion_date": "2028-09-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Hennepin Healthcare Research Institute.",
"sponsor_slug": "hennepin-healthcare-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07015996",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07015996",
"title": "Efficacy of Tezepelumab in Peanut Oral Immunotherapy: a Double-Blind, Randomized, Placebo-Controlled Trial",
"has_exemption": false,
"start_date": "2025-09-16",
"completion_date": "2028-09-16",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06990529",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06990529",
"title": "An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Leniolisib for Immune Dysregulation in Primary Immunodeficiency Disorders",
"has_exemption": false,
"start_date": "2025-04-29",
"completion_date": "2028-09-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Pharming Technologies B.V.",
"sponsor_slug": "pharming-technologies-bv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04889430",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04889430",
"title": "A Multicenter, Single-arm, Open Label Trial to Evaluate Efficacy and Safety of Oral, Twice Daily LNP023 in Adult aHUS Patients Who Are Naive to Complement Inhibitor Therapy",
"has_exemption": false,
"start_date": "2022-01-17",
"completion_date": "2028-09-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05239741",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05239741",
"title": "A Phase 3 Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Colorectal Cancer (MK-3475-C66)",
"has_exemption": false,
"start_date": "2022-04-02",
"completion_date": "2028-09-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05587712",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05587712",
"title": "A Phase 2 Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sotatercept (MK-7962) in Children From 1 to Less Than 18 Years of Age With PAH on Standard of Care",
"has_exemption": false,
"start_date": "2023-01-19",
"completion_date": "2028-09-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06057935",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06057935",
"title": "ICARuS II (Intraperitoneal Chemotherapy After cytoReductive Surgery): A Multicenter, Randomized Phase II Trial of Normothermic Intraperitoneal Chemotherapy and Intravenous Chemotherapy After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma",
"has_exemption": false,
"start_date": "2023-09-21",
"completion_date": "2028-09-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06799000",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06799000",
"title": "A Randomized, Double-blind, Double-dummy, Placebo-controlled, Multicenter, Phase 3 Study Assessing the Efficacy, Safety, and Tolerability of 2 Doses of Remibrutinib Over a 68-week Treatment Period in Adult Patients With Moderate to Severe Hidradenitis Suppurativa.",
"has_exemption": false,
"start_date": "2025-01-31",
"completion_date": "2028-09-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05948943",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05948943",
"title": "A Two-stage Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.",
"has_exemption": false,
"start_date": "2023-11-24",
"completion_date": "2028-09-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01499888",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01499888",
"title": "Phase I/II Study of Allogeneic Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease (SCD)",
"has_exemption": false,
"start_date": "2011-11-11",
"completion_date": "2028-09-23",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06882785",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06882785",
"title": "A Phase 3, Randomized, Two-part Study With a 5-week Double-blind Part (Randomized, Parallelgroup, Placebo-controlled) Followed by a 52-week Open-label Extension Part to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Patients With Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (DSM-5) Schizophrenia",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2028-09-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06726148",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06726148",
"title": "An Open-label, Multi-center, Phase I/II Study of ECI830 as a Single Agent and in Combination With Ribociclib and Endocrine Therapy in Patients With Advanced Hormone Receptor Positive, HER2-negative Breast Cancer and Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2025-04-03",
"completion_date": "2028-09-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06435429",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06435429",
"title": "A Phase 3, Randomized, Open-label, Multicenter, Controlled Study to Evaluate the Efficacy and Safety of Zanidatamab in Combination With Physician's Choice Chemotherapy Compared to Trastuzumab in Combination With Physician's Choice Chemotherapy for the Treatment of Participants With Metastatic HER2-positive Breast Cancer Who Have Progressed on, or Are Intolerant to, Previous Trastuzumab Deruxtecan Treatment",
"has_exemption": false,
"start_date": "2024-08-13",
"completion_date": "2028-09-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Jazz Pharmaceuticals",
"sponsor_slug": "jazz-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06687603",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06687603",
"title": "Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms",
"has_exemption": false,
"start_date": "2025-03-10",
"completion_date": "2028-09-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Case Comprehensive Cancer Center",
"sponsor_slug": "case-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06143891",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06143891",
"title": "A Randomized, Double-blind, Multicenter, Phase 3 Study to Evaluate Efficacy and Safety of Belumosudil in Combination With Corticosteroids Versus Placebo in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease (cGVHD)",
"has_exemption": false,
"start_date": "2024-01-23",
"completion_date": "2028-09-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05963074",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05963074",
"title": "Multicohort Study to Customize Ibrutinib Treatment Regimens for Patients With Previously Untreated Chronic Lymphocytic Leukemia",
"has_exemption": false,
"start_date": "2024-05-30",
"completion_date": "2028-09-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01697371",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01697371",
"title": "Phase I-II Trial of Stereotactic Body Proton Therapy for Patients With Liver Metastases",
"has_exemption": false,
"start_date": "2012-08-22",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Loma Linda University",
"sponsor_slug": "loma-linda-university",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01912651",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01912651",
"title": "The Role of Antibiotics in Full Thickness Skin Graft Survival for Facial Reconstructive Surgery",
"has_exemption": false,
"start_date": "2013-07-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02796937",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02796937",
"title": "An Open-Label, Multicenter Study to Evaluate the Long-term Safety of Weekly Intravenous Alpha1-Proteinase Inhibitor (Human), Modified Process 60 mg/kg in Subjects With Pulmonary Emphysema Due to Alpha1-Antitrypsin Deficiency",
"has_exemption": false,
"start_date": "2016-07-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Grifols Therapeutics LLC",
"sponsor_slug": "grifols-therapeutics-llc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03398135",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03398135",
"title": "A Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects With Ulcerative Colitis",
"has_exemption": false,
"start_date": "2018-08-28",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03900468",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03900468",
"title": "Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS)",
"has_exemption": false,
"start_date": "2020-03-05",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "MedtronicNeuro",
"sponsor_slug": "medtronicneuro",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04375033",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04375033",
"title": "CSP #2014 - Comparative Effectiveness of Two Formulations of Buprenorphine for Treating Opioid Use Disorder in Veterans (VA-BRAVE)",
"has_exemption": false,
"start_date": "2020-11-03",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04663347",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04663347",
"title": "A Phase 1b/2, Open-Label Trial to Assess the Safety and Preliminary Efficacy of Epcoritamab (GEN3013; DuoBody®-CD3xCD20) in Combination With Other Agents in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)",
"has_exemption": false,
"start_date": "2020-11-03",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04545736",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04545736",
"title": "Oral Metformin for Treatment of ABCA4 Retinopathy",
"has_exemption": false,
"start_date": "2020-11-23",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Eye Institute (NEI)",
"sponsor_slug": "national-eye-institute-nei",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04535271",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04535271",
"title": "TAGGED: A Phase 2 Study Using Low Dose/Metronomic Trabectedin, Gemcitabine, and Dacarbazine as 2nd/3rd/4th Line Therapy for Advanced Soft Tissue Sarcoma",
"has_exemption": false,
"start_date": "2021-09-09",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sarcoma Oncology Research Center, LLC",
"sponsor_slug": "sarcoma-oncology-research-center-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04914507",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04914507",
"title": "A Prospective Analysis of Long-Term Clinical Outcomes and 3D Spine Growth in Anterior Vertebral Body Tethering",
"has_exemption": false,
"start_date": "2021-09-09",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Pediatric Spine Foundation",
"sponsor_slug": "pediatric-spine-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04526938",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04526938",
"title": "Clinical Outcomes, Radiation Dosage, and Quality of Life in Patients Treated With Fenestrated Stent Grafts for Complex Thoracoabdominal and Abdominal Aortic Aneurysms, Thoracoabdominal Aortic Aneurysms Secondary to Aortic Dissections",
"has_exemption": false,
"start_date": "2021-09-20",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Medstar Health Research Institute",
"sponsor_slug": "medstar-health-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04372615",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04372615",
"title": "A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-Nmda Receptor Encephalitis and Assess Markers of Disease",
"has_exemption": false,
"start_date": "2022-03-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05374590",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05374590",
"title": "A Long-term, Single-Arm, Open-label, Multicenter Trial to Evaluate Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis",
"has_exemption": false,
"start_date": "2022-08-18",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05489887",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05489887",
"title": "A Phase II Study of Naxitamab Added to Induction Therapy for Subjects With Newly Diagnosed High-Risk Neuroblastoma",
"has_exemption": false,
"start_date": "2022-09-14",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Giselle Sholler",
"sponsor_slug": "giselle-sholler",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05613413",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05613413",
"title": "LUNG-IST-127: a Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab (CP) for Patients with Metastatic SqNSCLC with Disease Control Following Induction Therapy",
"has_exemption": false,
"start_date": "2022-12-28",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05765812",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05765812",
"title": "A Phase 1/2 Open-label Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma",
"has_exemption": false,
"start_date": "2023-05-15",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Debiopharm International SA",
"sponsor_slug": "debiopharm-international-sa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05941052",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05941052",
"title": "Supporting, Mobilizing and Accelerating Research for Tuberculosis Elimination (SMART4TB)- Technical Area (TA) 1: Diagnostics- Assessing Diagnostics At Point-of-care for Tuberculosis (ADAPT)",
"has_exemption": false,
"start_date": "2023-08-28",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05934487",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05934487",
"title": "A Prospective, Multi-Center, Open Label, Randomized Control Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class II-III Heart Failure Patients",
"has_exemption": false,
"start_date": "2023-11-29",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Endotronix, Inc.",
"sponsor_slug": "endotronix-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06056583",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06056583",
"title": "Postpartum Activity and Expression of BCRP and OCT1 Drug Transporters in the Mammary Gland",
"has_exemption": false,
"start_date": "2023-12-04",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05828069",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05828069",
"title": "Phase 2 Study of Tovorafenib (DAY101) in Relapsed and Refractory Langerhans Cell Histiocytosis",
"has_exemption": false,
"start_date": "2024-03-28",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06285695",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06285695",
"title": "Clareon Toric Single Arm Study (T2-T9)",
"has_exemption": false,
"start_date": "2024-04-10",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Alcon Research",
"sponsor_slug": "alcon-research",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06128356",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06128356",
"title": "Pilot Study of Dexmedetomidine Sublingual Film for the Ambulatory Treatment of Hyperadrenergic Autonomic Crisis in Patients With Familial Dysautonomia",
"has_exemption": false,
"start_date": "2024-06-01",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06564142",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06564142",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Povetacicept in Adults With Immunoglobulin A Nephropathy (RAINIER)",
"has_exemption": false,
"start_date": "2024-08-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Alpine Immune Sciences Inc, A Subsidiary of Vertex",
"sponsor_slug": "alpine-immune-sciences-inc-a-subsidiary-of-vertex",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06464692",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06464692",
"title": "A Phase 1b Study to Evaluate Safety and Pharmacokinetics (PK) of Telisotuzumab Adizutecan (ABBV-400) in Chinese Subjects With Unresectable Locally Advanced/Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2024-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06347796",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06347796",
"title": "Chronic Subdural Hematoma Treatment With Embolization Versus Surgery Study",
"has_exemption": false,
"start_date": "2024-11-01",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Medical Branch, Galveston",
"sponsor_slug": "the-university-of-texas-medical-branch-galveston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06782516",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06782516",
"title": "Native-RISE (Risk Identification for Suicide and Enhanced Care)",
"has_exemption": false,
"start_date": "2024-12-01",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins Bloomberg School of Public Health",
"sponsor_slug": "johns-hopkins-bloomberg-school-of-public-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06083480",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06083480",
"title": "Reducing Perioperative Oxidative Stress to Prevent Postoperative Chronic Pain Following Total Knee Arthroplasty",
"has_exemption": false,
"start_date": "2024-12-06",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06463028",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06463028",
"title": "An Open-label, Multi-Center, Phase 2 Clinical Trial Evaluating Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel, and a Substudy Evaluating PIKTOR With Paclitaxel Plus an Insulin-Suppressing Diet, in Patients With Advanced or Recurrent Endometrial Cancer",
"has_exemption": false,
"start_date": "2024-12-12",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Faeth Therapeutics",
"sponsor_slug": "faeth-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06699212",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06699212",
"title": "A Phase 3 Multicenter, Randomized, Open-label Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab Versus Standard of Care in the First-line Treatment of Patients With Locoregional Recurrence of Squamous Cell Carcinoma of the Head and Neck (HNSCC) With No Distant Metastases",
"has_exemption": false,
"start_date": "2024-12-24",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rakuten Medical, Inc.",
"sponsor_slug": "rakuten-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05046106",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05046106",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Efficacy and Safety Study of MLC1501 in Patients With Stroke",
"has_exemption": false,
"start_date": "2025-01-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Moleac Pte Ltd.",
"sponsor_slug": "moleac-pte-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06931561",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06931561",
"title": "Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Inova Health Care Services",
"sponsor_slug": "inova-health-care-services",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06649058",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06649058",
"title": "EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active Systemic Therapy Options",
"has_exemption": false,
"start_date": "2025-02-14",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06847321",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06847321",
"title": "A Randomized, Double-Blind, Placebo-Controlled Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease",
"has_exemption": false,
"start_date": "2025-02-17",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Lighthouse Pharmaceuticals, Inc.",
"sponsor_slug": "lighthouse-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06406777",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06406777",
"title": "Validation of MRI, CT and Pulmonary Function Tests for Early Detection of Chronic Lung Allograft Dysfunction",
"has_exemption": false,
"start_date": "2025-03-20",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sean Fain",
"sponsor_slug": "sean-fain",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05940493",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05940493",
"title": "A Phase 2 Multicenter, Double-blind, Randomized-controlled Study of Abemaciclib (CDK4 and 6 Inhibitor) in Newly Diagnosed RB-proficient Grade 3 Meningioma Participants",
"has_exemption": false,
"start_date": "2025-03-24",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Nader Sanai",
"sponsor_slug": "nader-sanai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06745908",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06745908",
"title": "ResQ201A: Randomized, Open-Label, Phase 3 Clinical Trial of N-803 Plus Tislelizumab and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy",
"has_exemption": false,
"start_date": "2025-05-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ImmunityBio, Inc.",
"sponsor_slug": "immunitybio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06880744",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06880744",
"title": "Phase 3b, Multicenter, Randomized, Open-Label Study of Risankizumab Compared to Vedolizumab for the Treatment of Adult Subjects With Moderate to Severe Ulcerative Colitis Who Are Naïve to Targeted Therapies",
"has_exemption": false,
"start_date": "2025-06-17",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07020221",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07020221",
"title": "A Phase 1/2a, Open-label Study of VS-7375, a KRAS G12D (ON/OFF) Inhibitor, as Monotherapy and in Combination, in Patients With Advanced KRAS G12D-Mutated Solid Tumors",
"has_exemption": false,
"start_date": "2025-06-24",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Verastem, Inc.",
"sponsor_slug": "verastem-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06649695",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06649695",
"title": "A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis",
"has_exemption": false,
"start_date": "2025-07-02",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "European Myeloma Network B.V.",
"sponsor_slug": "european-myeloma-network-bv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05494697",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05494697",
"title": "A Phase 2 Randomized Open-Label Controlled Study to Evaluate the Efficacy and Safety of Ampligen in Combination With Standard of Care Versus SOC Alone Following First-Line Therapy in Subjects With Locally Advanced Pancreatic Adenocarcinoma",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AIM ImmunoTech Inc.",
"sponsor_slug": "aim-immunotech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07047716",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07047716",
"title": "A Phase 3, Single-Arm Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Once-Yearly Intramuscular Lenacapavir for HIV Pre-exposure Prophylaxis (PrEP) in People With an Indication for PrEP",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06992999",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06992999",
"title": "Psilocybin for Treatment of Obsessive Compulsive Disorder",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Francisco A Moreno",
"sponsor_slug": "francisco-a-moreno",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07006805",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07006805",
"title": "RESET-MS: A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Participants With Multiple Sclerosis",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Cabaletta Bio",
"sponsor_slug": "cabaletta-bio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05864313",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05864313",
"title": "Gaze and Gait Training With Neuromodulation",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06833320",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06833320",
"title": "A Double-blind, Prospective, Randomized Trial of Propranolol for the Treatment of Postoperative Chylothorax After Open Cardiac Surgery",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "June Wu",
"sponsor_slug": "june-wu",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07043608",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07043608",
"title": "A Phase II Study of Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases in Patients Previously Treated With Immune Checkpoint Inhibitors",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Kelly Fitzgerald, MD",
"sponsor_slug": "kelly-fitzgerald-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07049055",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07049055",
"title": "A Phase I/IIa Randomized Clinical Trial to Evaluate the Efficacy of EGFR-targeted, PNU-159682-packaged Nanocells & Glycolipid-Packaged Nanocells in Combination With Gemcitabine & Nab-paclitaxel in Metastatic Pancreatic Ductal Adenocarcinoma",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Engeneic Pty Limited",
"sponsor_slug": "engeneic-pty-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07070219",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07070219",
"title": "A Single-Arm, Open-Label, Multi-Center, Phase 1b/ 2 Study to Evaluate the Safety, Efficacy, and Cellular Pharmacokinetic Profile of CTD402 in Participants With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and Lymphoblastic Lymphoma (T-LBL) (TENACITY-01)",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BIOHENG THERAPEUTICS US LLC",
"sponsor_slug": "bioheng-therapeutics-us-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04301843",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04301843",
"title": "Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma",
"has_exemption": false,
"start_date": "2020-09-25",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Giselle Sholler",
"sponsor_slug": "giselle-sholler",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04269902",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04269902",
"title": "Randomized, Phase III Study of Early Intervention With Venetoclax and Obinutuzumab Versus Delayed Therapy With Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): EVOLVE CLL/SLL Study",
"has_exemption": false,
"start_date": "2021-03-02",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05058651",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05058651",
"title": "Randomized Phase II/III Trial of First Line Platinum/Etoposide With or Without Atezolizumab (NSC#783608) in Patients With Poorly Differentiated Extrapulmonary Small Cell Neuroendocrine Carcinomas (NEC)",
"has_exemption": false,
"start_date": "2022-06-28",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05518188",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05518188",
"title": "A Phase 1/2 Open-label Intrathecal Administration of MELPIDA to Determine Its Safety and Efficacy for Patients with Spastic Paraplegia Type 50 (SPG50) Caused by Mutation in the AP4M1 Gene.",
"has_exemption": false,
"start_date": "2023-02-15",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Elpida Therapeutics SPC",
"sponsor_slug": "elpida-therapeutics-spc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05554328",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05554328",
"title": "A Randomized Trial of Selumetinib and Olaparib or Selumetinib Alone in Patients With Recurrent or Persistent RAS Pathway Mutant Ovarian and Endometrial Cancers: A ComboMATCH Treatment Trial",
"has_exemption": false,
"start_date": "2023-04-25",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06349434",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06349434",
"title": "The Utilization Effects of Powered Wearable Orthotics in Improving Upper Extremity Function and ADL in Persons With SCI",
"has_exemption": false,
"start_date": "2023-10-15",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Kessler Foundation",
"sponsor_slug": "kessler-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06099444",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06099444",
"title": "The Effects of Muscle Synergy-Based Biofeedback During Gait Rehabilitation for Individuals With Chronic Stroke",
"has_exemption": false,
"start_date": "2024-03-19",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Shirley Ryan AbilityLab",
"sponsor_slug": "shirley-ryan-abilitylab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06516978",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06516978",
"title": "A Prospective, Open-Label, Multicenter, Randomized Controlled Study Comparing the Efficacy and Safety of Polatuzumab Vedotin, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Combined With Orelabrutinib/Chidamide/Venetoclax/Lenalidomide/PD1 (Pola-RCHP-X) Versus RCHOP-X and Pola-RCHP in Previously Untreated Patients With Diffuse Large B-Cell Lymphoma",
"has_exemption": false,
"start_date": "2024-10-01",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The First Affiliated Hospital with Nanjing Medical University",
"sponsor_slug": "the-first-affiliated-hospital-with-nanjing-medical-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06635629",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06635629",
"title": "Phase II Prospective Evaluation of Desmopressin Stimulation Test Performance in ACTH-dependent Cushing s Syndrome",
"has_exemption": false,
"start_date": "2024-12-12",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06644183",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06644183",
"title": "A Phase 1/2, Open Label, Study of Roginolisib (IOA-244), an Orally Bioavailable, Selective PI3Kδ Inhibitor in Patients With Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL) in Combination With Venetoclax and Rituximab",
"has_exemption": false,
"start_date": "2025-03-19",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jennifer R. Brown, MD, PhD",
"sponsor_slug": "jennifer-r-brown-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06854159",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06854159",
"title": "A Phase 2 Study of Odronextamab in Relapsed/ Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Before and After Chimeric Antigen Receptor (CAR) T-Cell Therapy",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Davis",
"sponsor_slug": "university-of-california-davis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06745024",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06745024",
"title": "Radiation Therapy for High-Risk Asymptomatic Bone Metastases: A Pragmatic Multicenter Randomized Phase 3 Clinical Trial (PREEMPT)",
"has_exemption": false,
"start_date": "2025-04-14",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "NRG Oncology",
"sponsor_slug": "nrg-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06480760",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06480760",
"title": "Effects of Carnosine In Patients With Peripheral Arterial Disease Patients; Randomized Intervention Trial (CIPHER)",
"has_exemption": false,
"start_date": "2025-05-20",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Shahid Baba",
"sponsor_slug": "shahid-baba",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06986174",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06986174",
"title": "A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Shayna Sarosiek, MD",
"sponsor_slug": "shayna-sarosiek-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05935761",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05935761",
"title": "Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II Trial",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06412120",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06412120",
"title": "Single-Arm, Prospective, Multicenter Study Evaluating Safety, Tolerability, and Metabolism of Niraparib as Maintenance Following Front-Line Treatment for Ovarian Cancer in Women of African Ancestry",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06796998",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06796998",
"title": "Phase 2 Trial of Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Izidore Lossos, MD",
"sponsor_slug": "izidore-lossos-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07013591",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07013591",
"title": "Randomized Clinical Trial of β Nicotinamide Mononucleotide in Patients Undergoing CABG Surgery",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06408246",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06408246",
"title": "ACE-D: Accelerating Cognition-guided Signatures to Enhance Translation in Depression: Clinical Trial",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06833008",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06833008",
"title": "An Open-label, Phase I/II First-in-human, Dose Escalation and Confirmation Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic and Anti-tumour Activity of IPN01195 as Single Agent in Adult Participants With Advanced Solid Tumours",
"has_exemption": false,
"start_date": "2025-03-14",
"completion_date": "2028-10-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Ipsen",
"sponsor_slug": "ipsen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06202274",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06202274",
"title": "Clinical Study to Evaluate the Safety and Efficacy of Candela Technology",
"has_exemption": false,
"start_date": "2023-10-04",
"completion_date": "2028-10-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Candela Corporation",
"sponsor_slug": "candela-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06003387",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06003387",
"title": "Phase 3b, Open-label, Multicenter, Single-dose Study Investigating Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy Administered to Adult Subjects With Severe or Moderately Severe Hemophilia B With Detectable Pretreatment AAV5 Neutralizing Antibodies",
"has_exemption": false,
"start_date": "2024-01-30",
"completion_date": "2028-10-04",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07064122",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07064122",
"title": "A Modular Phase I/II, Open-label, Multicentre Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of AZD2962, an IRAK4 Inhibitor, as Monotherapy and in Combination With Other Agents, in Participants With Haematologic Neoplasms",
"has_exemption": false,
"start_date": "2025-07-04",
"completion_date": "2028-10-05",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05769777",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05769777",
"title": "An Open-Label Multinational, Multicenter Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis",
"has_exemption": false,
"start_date": "2023-04-03",
"completion_date": "2028-10-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00801489",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT00801489",
"title": "A Phase 2 Study of Fludarabine, Cytarabine, Filgrastim-sndz,Gemtuzumab Ozogamicin and Idarubicin in Newly Diagnosed Core Binding Factor Associated Acute Myelogenous Leukemia",
"has_exemption": false,
"start_date": "2007-04-04",
"completion_date": "2028-10-11",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06492291",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06492291",
"title": "A Phase 3, Open-label Extension Study to Evaluate the Safety and Efficacy of MK-0616 in Adults With Hypercholesterolemia",
"has_exemption": false,
"start_date": "2024-08-05",
"completion_date": "2028-10-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04246086",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04246086",
"title": "A Phase Ib/II, Open-Label, Multicenter Study With a Non-Randomized Stage Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab Plus Lenalidomide (+Len), and a Randomized Stage Evaluating the Safety, Tolerability, and Pharmacokinetics of SC Versus IV Mosunetuzumab + Len in Patients With Follicular Lymphoma",
"has_exemption": false,
"start_date": "2020-08-12",
"completion_date": "2028-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06072781",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06072781",
"title": "A Phase 3, Randomized, Open-Label Study of Combination Therapy With Avutometinib Plus Defactinib Versus Investigator's Choice of Treatment in Patients With Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) (RAMP 301)",
"has_exemption": false,
"start_date": "2024-03-18",
"completion_date": "2028-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Verastem, Inc.",
"sponsor_slug": "verastem-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06815003",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06815003",
"title": "Phase-2 Study of Vedolizumab Plus Post-Transplant Cyclophosphamide and Short Course Tacrolimus for Graft-versus-Host Disease Prevention After Reduced Intensity Conditioning Peripheral Blood Stem Cell Allogeneic Hematopoietic Cell Transplantation",
"has_exemption": false,
"start_date": "2025-04-18",
"completion_date": "2028-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04067336",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04067336",
"title": "A Phase 1/2 First in Human Study of the Menin-MLL(KMT2A) Inhibitor KO-539 in Patients With Relapsed or Refractory Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2019-09-12",
"completion_date": "2028-10-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Kura Oncology, Inc.",
"sponsor_slug": "kura-oncology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06572384",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06572384",
"title": "A Phase 3, Randomized, Double-Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Belimumab Administered Subcutaneously in Adults With Interstitial Lung Disease (ILD) Associated With Connective Tissue Disease (CTD)",
"has_exemption": false,
"start_date": "2024-09-11",
"completion_date": "2028-10-18",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03068819",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03068819",
"title": "Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant in Children and Adults",
"has_exemption": false,
"start_date": "2017-10-23",
"completion_date": "2028-10-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06459180",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06459180",
"title": "A Phase 3 Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (TroFuse-020/GOG-3101/ENGOT-cx20)",
"has_exemption": false,
"start_date": "2024-07-24",
"completion_date": "2028-10-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05755386",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05755386",
"title": "A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Iptacopan (LNP023) in Idiopathic Immune-complex-mediated Membranoproliferative Glomerulonephritis (IC-MPGN)",
"has_exemption": false,
"start_date": "2023-10-02",
"completion_date": "2028-10-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05451849",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05451849",
"title": "A Phase 1/2 Single Arm Open-Label Clinical Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer",
"has_exemption": false,
"start_date": "2022-06-21",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "TCR2 Therapeutics",
"sponsor_slug": "tcr2-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06430801",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06430801",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Program to Evaluate the Efficacy and Safety of Tulisokibart in Participants With Moderately to Severely Active Crohn's Disease",
"has_exemption": false,
"start_date": "2024-06-05",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06678659",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06678659",
"title": "A Phase 1 / 2, Open-Label Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer (DAHLIA)",
"has_exemption": false,
"start_date": "2024-11-21",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Recursion Pharmaceuticals Inc.",
"sponsor_slug": "recursion-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05952453",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05952453",
"title": "A Phase II Study in Newly Diagnosed Stage III/IV Epithelial Ovarian Cancer Evaluating Carbo/Taxol/Pembro in Patients Receiving Neoadjuvant Chemotherapy (NACT) Followed by Olaparib/Pembro Maintenance",
"has_exemption": false,
"start_date": "2025-02-17",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06873789",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06873789",
"title": "A Phase 1/2, Open-Label, Multicenter Study of INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06976619",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06976619",
"title": "The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03821129",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03821129",
"title": "GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study",
"has_exemption": false,
"start_date": "2019-07-25",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "W.L.Gore & Associates",
"sponsor_slug": "wlgore-associates",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04613596",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04613596",
"title": "A Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation",
"has_exemption": false,
"start_date": "2020-12-02",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mirati Therapeutics Inc.",
"sponsor_slug": "mirati-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04411823",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04411823",
"title": "Prediction of Post-laparoscopic Sleeve Gastrectomy Gastroesophageal Reflux Disease With an Endolumenal Functional Lumen Imaging Probe (EndoFLIP)",
"has_exemption": false,
"start_date": "2021-02-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05153772",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05153772",
"title": "A Phase 2 Open Label Study to Evaluate the Safety and Effectiveness of 212Pb-DOTAMTATE in Subjects With Somatostatin Receptor Expressing Neuroendocrine Tumors",
"has_exemption": false,
"start_date": "2021-12-21",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Orano Med LLC",
"sponsor_slug": "orano-med-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06342960",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06342960",
"title": "KYSA-3: A Phase 1/2, Open-Label, Multicenter Study of KYV-101, an Autologous Fully-Human Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis",
"has_exemption": false,
"start_date": "2022-12-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kyverna Therapeutics",
"sponsor_slug": "kyverna-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05259904",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05259904",
"title": "Study to Improve dEployment Related Asthma by Using L-citrulline Supplementation (SEALS)",
"has_exemption": false,
"start_date": "2023-03-08",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05977998",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05977998",
"title": "A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology",
"has_exemption": false,
"start_date": "2023-09-08",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05821959",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05821959",
"title": "A Trial of AAVAnc80-hOTOF Gene Therapy in Individuals With Sensorineural Hearing Loss Due to Otoferlin Gene Mutations",
"has_exemption": false,
"start_date": "2023-09-15",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Akouos, Inc.",
"sponsor_slug": "akouos-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06076304",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06076304",
"title": "Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Sinusitis",
"has_exemption": false,
"start_date": "2023-11-21",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Daniel Merenstein",
"sponsor_slug": "daniel-merenstein",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06140537",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06140537",
"title": "Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients",
"has_exemption": false,
"start_date": "2024-02-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05916235",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05916235",
"title": "Photobiomodulation for Management of Temporomandibular Disorder Pain",
"has_exemption": false,
"start_date": "2024-02-08",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06572683",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06572683",
"title": "Resonant Frequency rTMS: A Novel Approach to Target Circuit Modulation in Major Depressive Disorder",
"has_exemption": false,
"start_date": "2024-02-12",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06044623",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06044623",
"title": "Implementing Geriatric Assessment for Dose Optimization of CDK 4/6-inhibitors in Older Breast Cancer Patients - a Pragmatic Randomized-controlled Trial (IMPORTANT Trial)",
"has_exemption": false,
"start_date": "2024-04-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Region Örebro County",
"sponsor_slug": "region-orebro-county",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06590857",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06590857",
"title": "Phase 1b/2 Open-label Trial of 225Ac-DOTATATE (RYZ101) in Subjects with Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)-negative, Locally Advanced and Unresectable or Metastatic Breast Cancer Expressing Somatostatin Receptors (SSTRs) and Progressed After Antibody-drug Conjugates And/or Chemotherapy (TRACY-1).",
"has_exemption": false,
"start_date": "2024-07-19",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "RayzeBio, Inc.",
"sponsor_slug": "rayzebio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06216301",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06216301",
"title": "LUNAR-2: Pivotal, Randomized, Open-Label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab and Platinum-based Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2024-07-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NovoCure GmbH",
"sponsor_slug": "novocure-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06506422",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06506422",
"title": "SGLT2 Inhibition as a Therapeutic Strategy to Reverse Arterial Stiffening in Aging",
"has_exemption": false,
"start_date": "2024-08-18",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Missouri-Columbia",
"sponsor_slug": "university-of-missouri-columbia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06806930",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06806930",
"title": "Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)",
"has_exemption": false,
"start_date": "2024-10-03",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "George Washington University",
"sponsor_slug": "george-washington-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06330493",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06330493",
"title": "Prospective Multi-Center Randomized Controlled Trial to Evaluate the Safety and Efficacy of AcoArt Litos Paclitaxel Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Versus Non-Coated Standard Balloon Angioplasty for the Treatment of Infrapopliteal Obstructions in Patients With Chronic Limb-Threatening Ischemia",
"has_exemption": false,
"start_date": "2024-10-10",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Acotec Scientific Co., Ltd",
"sponsor_slug": "acotec-scientific-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05903131",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05903131",
"title": "A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia",
"has_exemption": false,
"start_date": "2024-10-24",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06614192",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06614192",
"title": "AndroMETa-CRC-064: An Open Label, Randomized, Controlled, Global Phase 3 Study Comparing Telisotuzumab Adizutecan (ABBV-400) Monotherapy to LONSURF (Trifluridine and Tipiracil) Plus Bevacizumab in Subjects With Refractory Metastatic Colorectal Cancer Expressing c-Met Protein Level Above a Defined Cutoff",
"has_exemption": false,
"start_date": "2024-11-08",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06825689",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06825689",
"title": "Unidos Contra el VPH: Screening Preference and Uptake of HPV Self-sampling Among Latinxs Along the US-Mexico Border",
"has_exemption": false,
"start_date": "2025-01-28",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas at Austin",
"sponsor_slug": "university-of-texas-at-austin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06942572",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06942572",
"title": "A Phase 1/2, First-in-Human, Open-label, Assessor-Masked, Randomized, Controlled, Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ATP Binding Cassette Subfamily A Member 4 (ABCA4) Gene",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Splice Bio",
"sponsor_slug": "splice-bio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06841055",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06841055",
"title": "A Phase II, Multisite, Open-label, Single Arm Trial of BNT327 in Combination With Docetaxel in Second-line Stage IV Non-small Cell Lung Cancer (NSCLC) Following Chemoimmunotherapy",
"has_exemption": false,
"start_date": "2025-03-03",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06533865",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06533865",
"title": "Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Adolescents and Young Adults With Functional Hypothalamic Amenorrhea",
"has_exemption": false,
"start_date": "2025-03-19",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06817668",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06817668",
"title": "Evaluating Tolerability of Elective Pelvic Ultra Hypofractionated Irradiation Treatment (ePUHRT) With High Dose Rate Brachytherapy Boost for Unfavorable and Higher Risk Prostate Cancer",
"has_exemption": false,
"start_date": "2025-03-27",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06891885",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06891885",
"title": "A Prospective, Open-label, Single-arm, Dose-escalation Study of the Safety and Tolerability of a Single Subretinal Uniocular Injection of Allogeneic Induced Pluripotent Stem Cell (iPSC)-derived Retinal Sheets (DSP-3077) in Adults with Retinitis Pigmentosa (RP)",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sumitomo Pharma America, Inc.",
"sponsor_slug": "sumitomo-pharma-america-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06727773",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06727773",
"title": "Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer",
"has_exemption": false,
"start_date": "2025-05-07",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06960577",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06960577",
"title": "A Phase IIIb, Open-label, Single-arm, Global Study of Perioperative Durvalumab With Neoadjuvant ddMVAC or Gem/Cis in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)",
"has_exemption": false,
"start_date": "2025-05-15",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06680752",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06680752",
"title": "A Phase 1/2, Open-label, Multicenter Trial to Assess the Safety and Efficacy of ARD103 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome",
"has_exemption": false,
"start_date": "2025-05-20",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ARCE Therapeutics, Inc.",
"sponsor_slug": "arce-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06205589",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06205589",
"title": "A Phase 2a/2b Study Evaluating Safety, Immunogenicity, and Therapeutic Efficacy of ID93 + GLA-SE Vaccination in Participants with Rifampicin-Susceptible Pulmonary TB",
"has_exemption": false,
"start_date": "2025-05-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections",
"sponsor_slug": "advancing-clinical-therapeutics-globally-for-hivaids-and-other-infections",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06693011",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06693011",
"title": "Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Cerus Endovascular, Inc.",
"sponsor_slug": "cerus-endovascular-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06980025",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06980025",
"title": "A Dose Escalation Study of Low Dose Aspirin for the Prevention of Recurrent Preterm Birth",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The George Washington University Biostatistics Center",
"sponsor_slug": "the-george-washington-university-biostatistics-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05882344",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05882344",
"title": "Cholinergic Deep Brain Stimulation for Alzheimer's Disease",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06224673",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06224673",
"title": "Phase II Open-label Study of ARX788 (Anti-HER2 Antibody Drug Conjugate (ADC)) for Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Laura Huppert, MD, BA",
"sponsor_slug": "laura-huppert-md-ba",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06225050",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06225050",
"title": "A Single-center Pilot Study Using TCRα/β and CD45RA Depleted Stem Cell Grafts From Haploidentical Donors for Hematopoietic Cell Transplantation in Adults(HAPLO2022)",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Miltenyi Biomedicine GmbH",
"sponsor_slug": "miltenyi-biomedicine-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07062354",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07062354",
"title": "A Phase II Study of Combined Amivantamab, Carboplatin and Paclitaxel in Unresectable Locally Recurrent or Metastatic Head and Neck Cancer",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04760860",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04760860",
"title": "a Randomized, Double Blind, Placebo Controlled Clinical Trial Exploring the Target Engagement and Tolerability of Terazosin Hydrochloride in Patients With Dementia With Lewy Bodies",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Qiang Zhang",
"sponsor_slug": "qiang-zhang",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05517655",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05517655",
"title": "BEGIN Novel ImagiNG Biomarkers",
"has_exemption": false,
"start_date": "2022-05-01",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Medical Center, Cincinnati",
"sponsor_slug": "childrens-hospital-medical-center-cincinnati",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05590923",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05590923",
"title": "The Efficacy of Steroid-Sparing Anti-Emetic Therapy in Patients Treated With High or Moderate Emetogenic Chemotherapy; Single Center Non-Inferiority Open Label Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2022-12-07",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The Guthrie Clinic",
"sponsor_slug": "the-guthrie-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06080503",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06080503",
"title": "G-FORCE: Phase II Randomized Study of Glottic Larynx Hypofractionated Radiotherapy Versus ConvEntional Radiotherapy",
"has_exemption": false,
"start_date": "2024-03-14",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06709495",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06709495",
"title": "Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas",
"has_exemption": false,
"start_date": "2025-01-27",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "David S Shulman, MD",
"sponsor_slug": "david-s-shulman-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06660810",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06660810",
"title": "Neoadjuvant Intralesional Injection of Talimogene Laherparepvec With Concurrent Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas",
"has_exemption": false,
"start_date": "2025-03-03",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "John Rieth",
"sponsor_slug": "john-rieth",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06819007",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06819007",
"title": "A Phase 3, Open-label, Multicenter, Randomized Trial of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy as First-line Maintenance Therapy in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01/ENGOT-ov89/GEICO144- O/GOG-3112)",
"has_exemption": false,
"start_date": "2025-03-19",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06973629",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06973629",
"title": "A Two-Part Phase 3b Randomized, Double-Blind, Placebo-Controlled, Followed by Open-Label Extension, Multicenter Study of the Efficacy and Safety of MSC-NTF (NurOwn) in Participants With With Early Symptomatic and Moderate Disease Presentation in Amyotrophic Lateral Sclerosis (ALS)",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brainstorm-Cell Therapeutics",
"sponsor_slug": "brainstorm-cell-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05931484",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05931484",
"title": "A Phase 2, Double-Blind, Multi-Center, Placebo-Controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of FHL-301 in Adult Patients With Parkinson's Disease",
"has_exemption": false,
"start_date": "2027-11-01",
"completion_date": "2028-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Forest Hills Lab",
"sponsor_slug": "forest-hills-lab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03907852",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03907852",
"title": "A Phase 1/2 Single Arm Open-Label Clinical Trial of Gavocabtagene Autoleucel (Gavo-cel) in Patients With Advanced Mesothelin-Expressing Cancer",
"has_exemption": false,
"start_date": "2019-04-15",
"completion_date": "2028-11-02",
"has_results": false,
"results_due": false,
"sponsor_name": "TCR2 Therapeutics",
"sponsor_slug": "tcr2-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05606614",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05606614",
"title": "REVEAL Adult Study: An Open-label, Randomized, Doseescalation- and Dose-expansion Study of the Safety and Preliminary Efficacy of a Single Intrathecal Administration of TSHA-102, an AAV9-Delivered Gene Therapy, in the Treatment of Adult Females With Rett Syndrome",
"has_exemption": false,
"start_date": "2023-03-06",
"completion_date": "2028-11-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Taysha Gene Therapies, Inc.",
"sponsor_slug": "taysha-gene-therapies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06152237",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06152237",
"title": "A Multicenter, Open Label, Randomized, Dose-Escalation and Dose-Expansion Study of the Safety, Tolerability, and Efficacy of a Single Intrathecal Administration of TSHA-102, an AAV9-Delivered Gene Therapy, for the Treatment of Pediatric Females With Rett Syndrome",
"has_exemption": false,
"start_date": "2023-12-12",
"completion_date": "2028-11-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Taysha Gene Therapies, Inc.",
"sponsor_slug": "taysha-gene-therapies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07011745",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07011745",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease",
"has_exemption": false,
"start_date": "2025-07-18",
"completion_date": "2028-11-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05348915",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05348915",
"title": "An Open-label Extension Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease Who Have Participated in an Inclacumab Clinical Trial",
"has_exemption": false,
"start_date": "2022-03-29",
"completion_date": "2028-11-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06534983",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06534983",
"title": "A Randomized Phase II, Double-Blind, Multicenter Study Evaluating the Efficacy and Safety of Autogene Cevumeran Plus Nivolumab Versus Nivolumab as Adjuvant Therapy in Patients With High-Risk Muscle-Invasive Urothelial Carcinoma",
"has_exemption": false,
"start_date": "2024-12-09",
"completion_date": "2028-11-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06504394",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06504394",
"title": "A Phase 2 Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)",
"has_exemption": false,
"start_date": "2024-10-14",
"completion_date": "2028-11-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06161519",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06161519",
"title": "Phase I/II Trial of PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications",
"has_exemption": false,
"start_date": "2024-01-31",
"completion_date": "2028-11-14",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05051033",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05051033",
"title": "Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)",
"has_exemption": false,
"start_date": "2022-02-21",
"completion_date": "2028-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Annetine Gelijns",
"sponsor_slug": "annetine-gelijns",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06144606",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06144606",
"title": "Phase 2 Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)",
"has_exemption": false,
"start_date": "2023-12-26",
"completion_date": "2028-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06571383",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06571383",
"title": "Weight Maintenance in Adolescents With Obesity; Long-Term Treatment With Semaglutide s.c.2.4 mg Once-weekly",
"has_exemption": false,
"start_date": "2024-09-17",
"completion_date": "2028-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05490277",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05490277",
"title": "Vibrotactile Coordinated Reset for the Treatment of Chronic Stroke",
"has_exemption": false,
"start_date": "2026-01-15",
"completion_date": "2028-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06499870",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06499870",
"title": "Optimizing Treatment and Advanced Multi-Imaging Response Evaluation for Very-High-Risk Prostate Cancer (OPTIMAL) - a Phase II Single Arm Study",
"has_exemption": false,
"start_date": "2024-09-06",
"completion_date": "2028-11-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06858735",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06858735",
"title": "HYPERION CCA: a Phase 2 Trial of Systemic Therapy With or Without Liver-directed Radiation Therapy for Patients With Advanced Intrahepatic Cholangiocarcinoma",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2028-11-19",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06112379",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06112379",
"title": "A Phase III, Open-label, Randomised Study of Neoadjuvant Datopotamab Deruxtecan (Dato-DXd) Plus Durvalumab Followed by Adjuvant Durvalumab With or Without Chemotherapy Versus Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab With or Without Chemotherapy for the Treatment of Adult Patients With Previously Untreated Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer (D926QC00001; TROPION-Breast04)",
"has_exemption": false,
"start_date": "2023-11-14",
"completion_date": "2028-11-20",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07011732",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07011732",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease",
"has_exemption": false,
"start_date": "2025-07-18",
"completion_date": "2028-11-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03686657",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03686657",
"title": "A 26-week Single Site, Randomized, Double-blind, Active-controlled, Parallel Group, Human PoC Study to Evaluate Superiority of RK-01, Valsartan Plus Celecoxib Addon to Metformin Versus Metformin Alone in Type 2 Diabetes Patients",
"has_exemption": false,
"start_date": "2025-10-10",
"completion_date": "2028-11-26",
"has_results": false,
"results_due": false,
"sponsor_name": "ARKAY Therapeutics",
"sponsor_slug": "arkay-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06947993",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06947993",
"title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase II Platform Study to Assess the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis",
"has_exemption": false,
"start_date": "2025-05-16",
"completion_date": "2028-11-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06184152",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06184152",
"title": "Contrast Ultrasound vs. Abbreviated MRI for Detection of HCC in Patients With Indeterminate Liver Nodules",
"has_exemption": false,
"start_date": "2023-11-28",
"completion_date": "2028-11-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06649110",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06649110",
"title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of LTP001 in Healthy Adult Participants (Part A) and to Evaluate the Efficacy and Safety of LTP001 for the Treatment of Participants With Pulmonary Arterial Hypertension (Part B)",
"has_exemption": false,
"start_date": "2024-10-24",
"completion_date": "2028-11-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03301506",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03301506",
"title": "ASSURE: An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)",
"has_exemption": false,
"start_date": "2017-12-12",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05079841",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05079841",
"title": "The Stimulation To Induce Mothers (STIM) Study: A Parallel Group Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2021-11-15",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05228145",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05228145",
"title": "A Phase 1/2 Intracerebroventricular and Intravitreal Administration of NGN-101 for Treatment of Neuronal Ceroid Lipofuscinosis (NCL) Subtype 5 (CLN5) Disease",
"has_exemption": false,
"start_date": "2022-01-31",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurogene Inc.",
"sponsor_slug": "neurogene-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05076617",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05076617",
"title": "An Open-Label, Multicenter, Outpatient Extension Study to Evaluate the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures",
"has_exemption": false,
"start_date": "2022-02-03",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05121376",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05121376",
"title": "A Phase 1/2 Open-Label, Dose-Escalation Study to Determine the Safety Tolerability & Efficacy of BMN 331 an AAV Vector-Mediated Gene Transfer of Human SERPING1 Gene in Subjects With HAE Due to Human C1-INH Deficiency",
"has_exemption": false,
"start_date": "2022-02-15",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BioMarin Pharmaceutical",
"sponsor_slug": "biomarin-pharmaceutical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05281731",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05281731",
"title": "Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma",
"has_exemption": false,
"start_date": "2022-04-18",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05429632",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05429632",
"title": "Randomized, Double-blind, Placebo-controlled, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Mocravimod as Adjunctive and Maintenance Treatment in Adult AML Patients Undergoing Allogeneic HCT",
"has_exemption": false,
"start_date": "2022-06-16",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Priothera SAS",
"sponsor_slug": "priothera-sas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05796375",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05796375",
"title": "Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance",
"has_exemption": false,
"start_date": "2023-11-17",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "White River Junction Veterans Affairs Medical Center",
"sponsor_slug": "white-river-junction-veterans-affairs-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05832229",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05832229",
"title": "Liver Cirrhosis Network (LCN) Rosuvastatin Efficacy and Safety for Cirrhosis in the United States (RESCU): A Double-Blind Randomized, Placebo-Controlled Phase 2 Study",
"has_exemption": false,
"start_date": "2023-12-07",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06157528",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06157528",
"title": "Diagnosis of Pelvic Endometriosis: a Preliminary Study on the Added Value of R2*MFGRE Sequence in MRI",
"has_exemption": false,
"start_date": "2023-12-20",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Zhenshen Ma",
"sponsor_slug": "zhenshen-ma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06075953",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06075953",
"title": "DCIS: RECAST Trial -Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment: a Breast Cancer Prevention Pilot Study",
"has_exemption": false,
"start_date": "2024-02-17",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "QuantumLeap Healthcare Collaborative",
"sponsor_slug": "quantumleap-healthcare-collaborative",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05940324",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05940324",
"title": "Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)",
"has_exemption": false,
"start_date": "2024-02-24",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06284122",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06284122",
"title": "A Phase III Randomized, Open-label, International, Multicenter Study Evaluating the Efficacy and Safety of Mosunetuzumab Plus Lenalidomide in Comparison to Anti-CD20 Monoclonal Antibody Plus Chemotherapy in Subjects With Previously Untreated FLIPI 2-5 Follicular Lymphoma",
"has_exemption": false,
"start_date": "2024-06-07",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The Lymphoma Academic Research Organisation",
"sponsor_slug": "the-lymphoma-academic-research-organisation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06487221",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06487221",
"title": "A Phase II Trial of Avutometinib in Combination With Defactinib in Metastatic Diffuse Gastric Cancer",
"has_exemption": false,
"start_date": "2024-10-28",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ryan H. Moy, MD, PhD",
"sponsor_slug": "ryan-h-moy-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06111313",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06111313",
"title": "A Phase 2 Risk Adapted Parallel Randomized Trial of MRI-Guided Lattice Stereotactic Focal Radiotherapy of the Prostate With or Without Ultra-Short Term Androgen Deprivation Therapy-The Miami UAdapt Trial",
"has_exemption": false,
"start_date": "2024-11-06",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06703476",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06703476",
"title": "A Clinically Integrated Randomized Clinical Trial (RCT) of Modifications to Radical Cystectomy and Postoperative Care",
"has_exemption": false,
"start_date": "2024-11-21",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06463457",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06463457",
"title": "Comeback From Long coursE ADT With RElugolix and Darolutamide in Hormone-sensitive Prostate Cancer (CLEARED)",
"has_exemption": false,
"start_date": "2024-12-13",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Atish Choudhury, MD",
"sponsor_slug": "atish-choudhury-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06846541",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06846541",
"title": "An Extension Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Long-term Safety, Efficacy, and Durability of Response to ESK-001",
"has_exemption": false,
"start_date": "2025-01-08",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Alumis Inc",
"sponsor_slug": "alumis-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06822738",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06822738",
"title": "A Prospective, Multicenter Clinical Study to Evaluate the Safety and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Subjects With Glaucoma",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06679634",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06679634",
"title": "Retinoblastoma Phase II Expanded Access Clinical Trial",
"has_exemption": false,
"start_date": "2025-02-21",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Targeted Therapy Technologies, LLC",
"sponsor_slug": "targeted-therapy-technologies-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06829238",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06829238",
"title": "Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use (MET-IH)",
"has_exemption": false,
"start_date": "2025-04-07",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06271590",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06271590",
"title": "The MAGICAL SV Trial - A Prospective, Multicenter, Randomized, Two-Arm, Single-blind Non Inferiority Trial to Evaluate the Safety and Efficacy of the MagicTouch™ Sirolimus-Coated Balloon in the Treatment of Small Vessels in Patients With Coronary Artery Disease.",
"has_exemption": false,
"start_date": "2025-05-20",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Concept Medical Inc.",
"sponsor_slug": "concept-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07013110",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07013110",
"title": "An Artificial Intelligence-powered Approach to Precision Immunotherapy of Human Arthritis - A Double-blind, Randomized, Placebo-controlled Clinical Trial",
"has_exemption": false,
"start_date": "2025-06-18",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Prof Salvatore Albani",
"sponsor_slug": "prof-salvatore-albani",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06434064",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06434064",
"title": "A Pilot, Single-Arm, Phase II Trial of Tamoxifen Plus Pegylated Liposomal Doxorubicin in Patients With Metastatic Triple Negative Breast Cancer",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07091279",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07091279",
"title": "Randomized Controlled Trial of Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism",
"has_exemption": false,
"start_date": "2025-07-21",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Jeremy Veenstra-vanderweele",
"sponsor_slug": "jeremy-veenstra-vanderweele",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06935474",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06935474",
"title": "Multi-center, Phase 1/2 Study of an Autologous Anti-CD20/BCMA CAR T Cell Therapy (C-CAR168) for the Treatment of Autoimmune Disease Refractory to Standard Therapy",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbelZeta, Inc.",
"sponsor_slug": "abelzeta-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07064759",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07064759",
"title": "A Phase 3, Randomized, Double-Masked, Active-Controlled Trial of a Single Intravitreal Injection of 4D-150 in Adults With Macular Neovascularization Secondary to Age-Related Macular Degeneration",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "4D Molecular Therapeutics",
"sponsor_slug": "4d-molecular-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06989775",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06989775",
"title": "EnCompass Clamp and the AtriClip in Box Lesion and Left Atrial Appendage EXclusion Procedure for the Prevention of New Onset of Atrial Fibrillation",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AtriCure, Inc.",
"sponsor_slug": "atricure-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06575075",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06575075",
"title": "A Double-blind, Placebo-controlled Study to Determine the Safety and Feasibility of Two Doses of Intravenous (2R, 6R)-Hydroxynorketamine (RR-HNK) in Adults With Obsessive-Compulsive Disorder",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Carolyn Rodriguez",
"sponsor_slug": "carolyn-rodriguez",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07047144",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT07047144",
"title": "A Phase 2, Double-Blind Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Apitegromab in Subjects <2 Years Old With Spinal Muscular Atrophy (SMA)",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Scholar Rock, Inc.",
"sponsor_slug": "scholar-rock-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}